Les Laboratoires Servier SAS - Company Profile

Powered by

All the data and insights you need on Les Laboratoires Servier SAS in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Les Laboratoires Servier SAS Strategy Report

  • Understand Les Laboratoires Servier SAS position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Les Laboratoires Servier SAS: Overview

Select Item

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company's portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders, and others. The company also provides generic drugs and contract development and manufacturing services across its global network. The company also provides digital therapeutic solutions through its e-health division, WeHealth Digital Medicine. It sells products in Europe, America, Middle East, Africa, and Asia. Servier headquartered in Suresnes, Ile-de-France, France.

 Gain a 360-degree view of Les Laboratoires Servier SAS and make more informed decisions for your business Gain a 360-degree view of Les Laboratoires Servier SAS and make more informed decisions for your business Find out more
Headquarters France
Address 50 Rue Carnot, Suresnes, Ile-de-France, 92284
Website www.servier.com
No of Employees 21,400
Industry Pharmaceuticals and Healthcare
Revenue (2022) $5.2B
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Les Laboratoires Servier SAS premium industry data and analytics

510+

Clinical Trials

Determine Les Laboratoires Servier SAS go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

470+

Marketed Drugs

Understand Les Laboratoires Servier SAS’s commercialized product portfolio to stay one step ahead of the market.

190+

Catalyst Calendar

Proactively evaluate Les Laboratoires Servier SAS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

150+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Les Laboratoires Servier SAS’s relevant decision makers and contact details.

140+

Pipeline Drugs

Identify which of Les Laboratoires Servier SAS’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

19+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

9

Sales & Consensus Forecasts

Understand the current and future drug revenue for Les Laboratoires Servier SAS and assess market opportunity for new entrants with patient population 8-year forecasts.

2

Investigators

Review investigator profiles and find information on trial contacts across Les Laboratoires Servier SAS, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Les Laboratoires Servier SAS’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Branded and Generic Drugs: Contract Development and Manufacturing Services Hyperium
Ear Nose Throat Disorders Preterax
Oncology Coversyl
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Les Laboratoires Servier SAS portfolio and identify potential areas for collaboration Understand Les Laboratoires Servier SAS portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In December, the company and CStone Pharmaceuticals entered into an agreement in which Servier will obtain the rights to develop and market TIBSOVO (ivosidenib tablets) in Greater China and Singapore.
2023 Contracts/Agreements In May, the company entered into an agreement with Aitia to create new Gemini Digital twins to help in the fight against Pancreatic Cancer.
2023 Contracts/Agreements In April, the company entered into an agreement with Specifica and Symphogen A/S for the development of drugs in particular in oncology, neuroscience and immune-inflammation.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Les Laboratoires Servier SAS Pfizer Inc Sanofi Ipsen SA Laboratoires Pierre Fabre SA
Headquarters France United States of America France France France
City Suresnes New York Paris Boulogne-Billancourt Castres
State/Province Ile-de-France New York Ile-de-France Bourgogne -
No. of Employees 21,400 88,000 87,994 5,072 9,600
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Olivier Laureau Chief Executive Officer; President Senior Management 2014 -
Claude Bertrand Chief Scientific Officer; Executive Vice President - Research and Development Senior Management 2018 -
Damien Catoir Executive Vice President; General Counsel; Secretary Senior Management 2023 -
Arnaud Lallouette Executive Vice President - Global Medical & Patient Affairs Senior Management 2023 -
Virginie Dominguez Executive Vice President - Digital, Data and Information Systems Senior Management 2020 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Les Laboratoires Servier SAS key executives to enhance your sales strategy Gain insight into Les Laboratoires Servier SAS key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward